Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protection of Renal Function After Liver Transplant Using Everolimus Monotherapy as the Immunosuppression Regimen

NCT04063865 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.

NCT NCT04063865
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04063865 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protection of Renal Function After Liver Transplant Using Everolimus Monotherapy as the Immunosuppression Regimen
Lead sponsor
Indiana University
Phase
Phase 3
Overall status
Terminated
Start date
May 9, 2019
Completion date
July 2, 2020
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney failure